PRKAA1 and Hyperglycemia: Because of its favorable global metabolic effects when activated, the higher expression of AMPK found in the present study may be a compensating mechanism to counteract the hyperglycaemia detected in the BPA, HFD and HFD-BPA groups, which probably is due to an incomplete blockade of liver gluconeogenesis.